Health Condition 1: K006- Disturbances in tooth eruption
Conditions
Interventions
Intervention1: Drug: Drug - Serratiopeptidase in combination with Diclofenac and Flavonoids in combination with Diclofenac
Route : Oral
Duration : 3 Days
Dosage for Serratiopeptidase in combinatio
Sponsors
Dr Nitin B
Eligibility
Inclusion criteria
Inclusion criteria: 1. ASA I patients in the age group of 18- 40 years with either gender 2. All impacted mandibular third molars requiring surgical extraction 3. CLASS I, CLASS II, POSITION-A and POSITION-B Impacted third molar According to Pell and Gregory classification 4.Patient willing to participate in the study
Exclusion criteria
Exclusion criteria: 1.Acute infection 2.Patient allergic to administrated drugs 3.Patients with Gastric Ulcers 4.Patient with bleeding disorders 5.Pregnancy and Lactating women 6.Immunocompromised patient Mentally challenged patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcome: Pain Secondary Outcome: Swelling and TrismusTimepoint: Both Primary and Secondary outcomes are measured on the pre operative day (Day 0) and post operative days (Day 1and Day 3) that is during the course of the intervention administered and post operative days (Day 7 and Day 12) for follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| Swelling TrismusTimepoint: 1ST POST-OP DAY 3RD POST OP DAY 7TH POST OP DAY 12TH POST OP DAY | — |
Countries
India
Contacts
Public ContactDr Nitin B
Sri Venkateshwaraa Dental College
Outcome results
None listed